3D Mammary Epithelial Cell Models: A Goldmine of DCIS Biomarkers and Morphogenetic Mechanisms.
3D HME1 models
DCIS biomarkers and morphogenetic mechanisms
ductal carcinoma in situ (DCIS)
protein-miRNA pairs
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
23 Jan 2019
23 Jan 2019
Historique:
received:
10
12
2018
revised:
14
01
2019
accepted:
18
01
2019
entrez:
26
1
2019
pubmed:
27
1
2019
medline:
27
1
2019
Statut:
epublish
Résumé
Breast ductal carcinoma in situ (DCIS) has been typically recognized by pathologists on the basis of aberrant mammary duct morphology. Thus, there are increasing efforts to detect DCIS biomarkers and druggable targets. In this study we focused on the molecular mechanism involving Annexin A8 (ANXA8), a Ca
Identifiants
pubmed: 30678048
pii: cancers11020130
doi: 10.3390/cancers11020130
pmc: PMC6407115
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Cancer Institute
ID : R01CA127614
Organisme : Friends For an Earlier Breast Cancer Test
ID : no number
Organisme : National Cancer Institute
ID : P30CA016056
Références
Cancer Res. 2002 Aug 15;62(16):4599-604
pubmed: 12183414
J Cell Sci. 2002 Dec 1;115(Pt 23):4419-31
pubmed: 12414989
Blood. 1992 Apr 1;79(7):1802-10
pubmed: 1313714
Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9064-8
pubmed: 1384042
Cell. 2003 Dec 26;115(7):787-98
pubmed: 14697198
Cell. 2005 Jan 14;120(1):15-20
pubmed: 15652477
Mol Endocrinol. 2005 Jun;19(6):1584-92
pubmed: 15831516
Nat Rev Cancer. 2005 Sep;5(9):675-88
pubmed: 16148884
Ann Intern Med. 2005 Sep 20;143(6):446-57
pubmed: 16172443
Dev Dyn. 2005 Dec;234(4):892-9
pubmed: 16217742
Mol Cell Biol. 2005 Dec;25(23):10591-603
pubmed: 16287870
Cancer Res. 2006 Nov 1;66(21):10308-14
pubmed: 17079450
J Circadian Rhythms. 2008 Mar 11;6:4
pubmed: 18334030
Med Clin North Am. 2008 Sep;92(5):1115-41, x
pubmed: 18721655
Nucleic Acids Res. 2009 Jan;37(Database issue):D98-104
pubmed: 18927107
PLoS One. 2009;4(1):e4305
pubmed: 19173001
Oncogene. 2009 Nov 12;28(45):4034-40
pubmed: 19749800
J Cell Mol Med. 2010 Jun;14(6A):1358-70
pubmed: 19961547
Genes Dev. 2010 Jan 15;24(2):171-82
pubmed: 20080953
Breast Cancer Res Treat. 2010 Oct;123(3):613-25
pubmed: 20549336
J Pathol. 2011 Jan;223(2):307-17
pubmed: 21125683
Cell Physiol Biochem. 2011;27(3-4):207-16
pubmed: 21471709
Genome Res. 2012 Feb;22(2):398-406
pubmed: 21908773
Nat Cell Biol. 2011 Oct 23;13(12):1443-9
pubmed: 22020439
Breast Cancer Res. 2012 Feb 21;14(1):R34
pubmed: 22353773
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W498-504
pubmed: 22649059
PLoS One. 2012;7(8):e42390
pubmed: 22870325
Cell Cycle. 2012 Oct 1;11(19):3691-700
pubmed: 22935699
Nucleic Acids Res. 2012 Dec;40(22):11673-83
pubmed: 23034802
PLoS One. 2012;7(12):e51702
pubmed: 23240057
Bioinformatics. 2013 Mar 1;29(5):638-44
pubmed: 23325619
Tumour Biol. 2013 Jun;34(3):1361-70
pubmed: 23529451
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Oncol Rep. 2014 Mar;31(3):1357-63
pubmed: 24366472
Clin Cancer Res. 2014 May 1;20(9):2326-37
pubmed: 24634376
Bioinformatics. 2014 Aug 1;30(15):2237-8
pubmed: 24651967
Breast Cancer Res. 2014 Nov 14;16(6):473
pubmed: 25394902
Cancer Lett. 2016 Oct 1;380(2):375-83
pubmed: 27422542
Cell Cycle. 2016 Sep 16;15(18):2515-26
pubmed: 27485818
Oncotarget. 2016 Dec 27;7(52):87064-87080
pubmed: 27894085
Sci Rep. 2017 Jun 26;7(1):4243
pubmed: 28652618
Oncotarget. 2017 Oct 6;8(59):99978-99989
pubmed: 29245954
Cancers (Basel). 2018 Apr 01;10(4):null
pubmed: 29614786
Front Endocrinol (Lausanne). 2018 May 04;9:219
pubmed: 29780357
Sci Rep. 2018 Aug 16;8(1):12252
pubmed: 30115973
Exp Cell Res. 1997 Oct 10;236(1):16-28
pubmed: 9344581